Sarepta Therapeutics
SRPT
NZ$31.52
Share price
0.58%
Change (1 day)
-88.23%
Change (1 year)
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.
Sarepta Therapeutics (SRPT) - Cash on Hand
Cash on Hand as of March 2025 : NZ$0.86 Billion
According to Sarepta Therapeutics
's latest financial reports the company has NZ$0.86 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sarepta Therapeutics - Cash on Hand chart (from 1997 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | NZ$2.40 B | -81.65% |
| 2023-12-31 | NZ$13.09 B | -15.77% |
| 2022-12-31 | NZ$15.54 B | 401.77% |
| 2021-12-31 | NZ$3.09 B | 15.3% |
| 2020-12-31 | NZ$2.68 B | 60.88% |
| 2019-12-31 | NZ$1.67 B | -4.57% |
| 2018-12-31 | NZ$1.75 B | -79.24% |
| 2017-12-31 | NZ$8.43 B | 242.05% |
| 2016-12-31 | NZ$2.46 B | 776.36% |
| 2015-12-31 | NZ$0.28 B | 4.76% |
| 2014-12-31 | NZ$0.26 B | -14.15% |
| 2013-12-31 | NZ$0.31 B | 37.08% |
| 2012-12-31 | NZ$0.22 B | -26.4% |
| 2011-12-31 | NZ$0.30 B | 611.86% |
| 2010-12-31 | NZ$43.53 M | -34.49% |
| 2009-12-31 | NZ$66.46 M | 236.16% |
| 2008-12-31 | NZ$19.77 M | -39.6% |
| 2007-12-31 | NZ$32.73 M | -87.3% |
| 2006-12-31 | NZ$0.25 B | -29.32% |
| 2005-12-31 | NZ$0.36 B | 404.01% |
| 2004-12-31 | NZ$72.38 M | -49.51% |
| 2003-12-31 | NZ$0.14 B | -99.92% |
| 2002-12-31 | NZ$172.67 B | 5023.41% |
| 2001-12-31 | NZ$3.37 B | -8.39% |
| 2000-12-31 | NZ$3.67 B | 210.4% |
| 1999-12-31 | NZ$1.18 B | 22.91% |
| 1998-12-31 | NZ$0.96 B | -58.03% |
| 1997-12-31 | NZ$2.29 B | 560.87% |
| 1996-12-31 | NZ$0.34 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | NZ$13.16 B | 1,416.18% | 🇺🇸 USA |
 Novavax NVAX | NZ$1.21 B | 39.93% | 🇺🇸 USA |
 Avidity Biosciences RNA | NZ$2.29 B | 163.96% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | NZ$0.49 B | -43.55% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | NZ$4.37 B | 403.52% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | NZ$3.36 B | 287.78% | 🇺🇸 USA |
 Insmed INSM | NZ$1.99 B | 129.44% | 🇺🇸 USA |